Additionally, semaglutide tablets was evaluated as a second-line and third-line therapy across the included studies as an add-on to: metformin alone, SU alone, metformin and SU, metformin and an SGLT2 inhibitor, basal insulin with or without metformin, glinide, TZD, and alpha-glucosidase inhibitors
Samourjian provides the necessary oversight to ensure these medications work effectively for your specific health profile
2 World Journal of Gastroenterology (PMC)Sikiric P et al
However, the trial's low event rate and reliance on serum creatinine to assess eGFR, which may be influenced by muscle mass changes, limit the robustness of its conclusions
Early intervention makes a difference